Clovis Oncology's GAAP loss for 2021 was $264.524 million, down 28.4% from $369.212 million in the prior year. Revenue declined 9.6% to $148.757 million from $164.522 million a year earlier.
Clovis Oncology's GAAP loss for 2021 was $264.524 million, down 28.4% from $369.212 million in the prior year. Revenue declined 9.6% to $148.757 million from $164.522 million a year earlier. 
ir.clovisoncology.com
English (US) 